PCOS
4 articles on PCOS, written by Shotlee and medically reviewed for clinical accuracy.
Aston Gynaecologist Investigates Ozempic, Mounjaro Impact on PCOS
A leading gynaecologist at Aston Medical School is probing whether GLP-1 drugs like Ozempic and Mounjaro could transform care for women with PCOS. With a £60,000 NHS grant, Dr Shagaf Bakour aims to evaluate their effects on metabolic health and fertility. This investigation highlights hope for better treatment pathways amid rising interest in these weight loss jabs.
5 min read
Aston University Investigates Weight-Loss Drugs for PCOS Treatment
A gynaecologist at Aston University has won a £60,000 NHS research grant to probe the potential of weight-loss drugs like Ozempic and Mounjaro in treating polycystic ovary syndrome (PCOS). This initiative aims to evaluate their impact on metabolic health and fertility in affected women. Discover the project's details and why it matters for patient care.
6 min read
GLP-1 Drugs: Weight Loss Benefits & Fertility Risks for Women
GLP-1 receptor agonists excel in weight management and glucose control, but their effects on women's reproductive health demand attention. These drugs can restore ovulation in obese women with insulin resistance, yet they risk unplanned pregnancies and are unsafe during gestation. Consult experts before use.
3 min read
Exploring Microdosing Mounjaro for a Debilitating, Common Condition
This article examines the emerging trend of microdosing GLP-1 medications like Mounjaro for various health conditions. It delves into personal experiences, potential benefits, and expert warnings regarding unsupervised use.
6 min read